Close Menu

Why So Few?

Some clinical cancer trials don't attract the wanted number of participants. And there are a number of reasons why, such as competing trials, conditions with low annual incidence, and whether they focus on older treatments rather than newer ones, according to researchers from the University of Washington and the Fred Hutchinson Cancer Research Center.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Matt Hancock, the UK health secretary, is calling for the swift rollout of predictive genetic tests, the Guardian reports.

A WHO panel is calling for a global registry of human germline gene-editing projects, according to Stat News.

Vox writes that lab mishaps involving pathogens are quite common.

In Genome Biology this week: analysis of wild and cultivated peach genomes, Hi-C-based pipeline for assembling microbial genomes from metagenomic data, and more.